Drug allergy: A 2022 practice parameter update
David A. Khan(Southwestern Medical Center), Dana Wallace(Nova Southeastern University), Anne K. Ellis(Queen's University), Matthew Greenhawt(University of Michigan), Julie Wang(Shanghai Jiao Tong University), Aleena Banerji(Massachusetts General Hospital), Roland Solensky(Oregon State University), Phil Lieberman(University of Southern California), Kimberly G. Blumenthal(Jacksonville College), Matthew A. Rank(Mayo Clinic in Arizona), Caroline C. Horner(Washington University in St. Louis), David B.K. Golden(Johns Hopkins University), Derek K. Chu(McMaster University), Elizabeth J. Phillips(Murdoch University), Jonathan A. Bernstein(Bernstein Clinical Research Center), Andrew A. White(Scripps Health), John Oppenheimer(Rutgers, The State University of New Jersey), Marcus Shaker(Dartmouth College), Dennis K. Ledford(University of South Florida), David R. Stukus(The Ohio State University)
Cited by 504
Related Papers
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
|The Lancet|2020|4.1k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k